Market Watch column provides a thorough analysis of stock market fluctuations and expert ratings.

Hourly Market Review - Dec 31, 2024 14 PM

Market BriefTuesday, Dec 31, 2024 2:00 pm ET

1min read

Movers of the hour:

Baird Medical is up 470.49% at $5.99.

Verastem is up 46.32% at $5.37.

Scully Royalty is up 41.18% at $9.77.

Maiden Holdings is up 29.67% at $1.60.

Park Ha Biological is up 29.28% at $6.27.

Here are the top stocks upgraded by Wall Street analyst:

Apple has received a rating of Buy from Wedbush with target price increased to $325 from $300.

Apple has received a rating of Buy from Morgan Stanley with target price increased to $273 from $273.

Apple has received a rating of Strong Buy from Needham with target price increased to $260 from $260.

Apple has received a rating of Buy from Wedbush with target price increased to $300 from $300.

Microsoft has received a rating of Strong Buy from Loop Capital with target price increased to $550 from $500.

Microsoft has received a rating of Strong Buy from UBS with target price increased to $525 from $500.

Microsoft has received a rating of Strong Buy from Stifel with target price increased to $515 from $475.

Microsoft has received a rating of Buy from Mizuho with target price increased to $510 from $480.

Alphabet A has received a rating of Strong Buy from B of A Securities with target price increased to $210 from $210.

Alphabet A has received a rating of Buy from JP Morgan with target price increased to $232 from $212.

Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.